From Platinum Partner Greenwich Biosciences: EPIDIOLEX® in the Long Term Care SettingImage Banner

From Platinum Partner Greenwich Biosciences: EPIDIOLEX® in the Long Term Care Setting

You are here

From Platinum Partner Greenwich Biosciences: EPIDIOLEX® in the Long Term Care Setting

December 9, 2021 - 1:00pm to 2:00pm
Eastern Standard Time

 Greenwich BiosciencesANCOR Platinum Partner Greenwich Biosciences has developed EPIDIOLEX, the first and only FDA approved cannabinoid designed specifically to address seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, and Tuberous Sclerosis Complex (TSC).

During this webinar you'll hear from Greenwich Biosciences and Nanette Wrobel, a registered pharmacist from ANCOR Gold Partner Tarrytown Expocare Pharmacy. They will discuss the latest updates regarding EPIDIOLEX, cannabinoid science, results from randomized clinical trials, plus labeling information.

Register to join Greenwich Biosciences for this webinar, Thursday, December 9 at 1 pm EST.

Registration